Sort
130,381 grants matching “hiv”
Center for Point-of-Care Technologies Research for Sexually Transmitted Diseases
$1,556,539Yukari C Manabe · Johns Hopkins University · U54 · FY2019 · EB
VANDERBILT ADULT AIDS CLINICAL TRIALS UNIT
$1,556,340Vanderbilt University · U01 · FY2004 · AI
Investigating the development of AIDs and non-AIDS defining cancers in aged SIV-infected rhesus macaques.
$1,555,244Scott W Wong · Oregon Health & Science University · R01 · FY2017 · CA
Revealing Reservoirs during Rebound (R3)
$1,555,227David Mitchell Smith · University Of California, San Diego · P01 · FY2017 · AI
Comprehensive NeuroAIDS Core Center
$1,555,042Kamel Khalili · Temple Univ Of The Commonwealth · P30 · FY2013 · MH
Antibody Neutralization Mechanisms
$1,554,806Tongqing Zhou · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
NEVIRAPINE+ZIDOVUDINE--PREVENT PERINATAL HIV IN THAILAND
$1,554,692Harvard University (Sch Of Public Hlth) · R01 · FY2001 · HD
Duke University Center for Translational Research
$1,554,479Duke University · P30 · FY2005 · AI
Sex Hormone Regulation of Innate Immunity in Women &Men
$1,554,427Dartmouth College · P01 · FY2004 · AI
SUPPORTING THE IMPLEMENTATION AND EXPANSION OF HIGH QUALITY HIV PREVENTION,CARE A
$1,554,206Dr. Anthony Amoroso · University Of Maryland Baltimore · U2G · FY2013 · PS
Development of a Manufacturing Process for a Novel TB Vaccine
$1,553,871Vijay Yabannavar · Emergent Product Development Gaithersbur · R01 · FY2014 · AI
Development of a Manufacturing Process for a Novel TB Vaccine
$1,553,871Jeffrey Philip Welch · Emergent Product Development Gaithersbur · R01 · FY2015 · AI
Development of a Manufacturing Process for a Novel TB Vaccine
$1,553,871Jeffrey Philip Welch · Emergent Product Development Gaithersbur · R01 · FY2016 · AI
Development of a Manufacturing Process for a Novel TB Vaccine
$1,553,871Vijay Yabannavar · Emergent Product Development Gaithersbur · R01 · FY2012 · AI
Factors Influencing Genetic Transcription Initiation And Termination
$1,553,861Robert J Crouch · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2019 · HD
Natural Products Discovery and Characterization Through Network Collaborations
$1,553,705Kirk Gustafson · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Partnership for Prevention of HPV-Associated Cancers in People Living with HIV: Brazil, Mexico, and Puerto Rico
$1,553,664Grant B. Ellsworth · Weill Medical Coll Of Cornell Univ · U54 · FY2023 · CA
Optimization Of HIV Specific Immune Responses In Vivo
$1,553,207Robert A Seder · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
COOPERASALUD II: TECHNICAL ASSISTANCE TO STRENGTHEN POST-PANDEMIC HIV PREVENTION AND CONTROL CAPACITIES IN THE PERUVIAN ARMED FORCES
$1,553,046Universidad Peruana Cayetano Heredia · · FY2025 · Defense Health Agency
Basic and Comparative Studies of CCR5 Inhibition to Prevent HIV Transmission
$1,552,707Michael Marcel Lederman · Case Western Reserve University · U19 · FY2009 · AI
Colaboracion Evita: HPV-Related Cancer Prevention Partnership Center
$1,552,556Margaret M Madeleine · Fred Hutchinson Cancer Center · U54 · FY2024 · CA
COMPREHENSIVE HIV PREVENTION PROJECT FOR HEALTH DEPTS
$1,552,460Deann Gruber · Louisiana State Office Of Public Health · U62 · FY2016 · PS
Immunogen Design for Induction of HIV distal gp41 broadly neutralizing antibodies
$1,552,366S Munir Alam · Duke University · P01 · FY2021 · AI
DEVELOPMENT OF AN AIDS PROTOTYPE VACCINE USING SIV
$1,552,287University Of Pittsburgh At Pittsburgh · P01 · FY2001 · AI
Dissecting the mechanisms of HIV resistance in vivo to broadly neutralizing antibodies
$1,552,089Alon Herschhorn · University Of Minnesota · U01 · FY2023 · AI